Biomarkers in Osteoarthritis: Value of Proteomics

[1]  L. Wehenkel,et al.  Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis , 2011, Annals of the rheumatic diseases.

[2]  C. Cooper,et al.  Value of biomarkers in osteoarthritis: current status and perspectives , 2013, Annals of the rheumatic diseases.

[3]  K. Huang,et al.  YKL-40: A Potential Biomarker for Osteoarthritis , 2009, The Journal of international medical research.

[4]  M. Yaron,et al.  Serum amyloid A‐derived peptides, present in human rheumatic synovial fluids, induce the secretion of interferon‐γ by human CD4 + T‐lymphocytes , 2000, FEBS letters.

[5]  Hans-Jürgen Thiesen,et al.  Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis , 2002, Electrophoresis.

[6]  D J Hunter,et al.  Classification of osteoarthritis biomarkers: a proposed approach. , 2006, Osteoarthritis and cartilage.

[7]  Koichi Masuda,et al.  A systems biology approach to synovial joint lubrication in health, injury, and disease , 2012, Wiley interdisciplinary reviews. Systems biology and medicine.

[8]  M. Beekman,et al.  Metabolic health in families enriched for longevity is associated with low prevalence of hand osteoarthritis and influences OA biomarker profiles , 2012, Annals of the rheumatic diseases.

[9]  P. Delmas,et al.  Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. , 2000, Arthritis and rheumatism.

[10]  M. Nevitt,et al.  Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. , 2008, Osteoarthritis and cartilage.

[11]  O. Nemirovskiy,et al.  Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. , 2007, Analytical biochemistry.

[12]  N. Oreiro,et al.  Identification of a panel of novel serum osteoarthritis biomarkers. , 2011, Journal of proteome research.

[13]  B. Mazières,et al.  Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study , 2007, Annals of the rheumatic diseases.

[14]  M. L. Pucinelli,et al.  Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation , 2007, Scandinavian journal of rheumatology.

[15]  Nandini A. Sahasrabuddhe,et al.  Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients , 2014, Clinical Proteomics.

[16]  T. Uchida,et al.  Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. , 2002, Journal of proteome research.

[17]  P. Geurts,et al.  Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. , 2005, Arthritis and rheumatism.

[18]  J. Kirwan,et al.  Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? , 2007, Arthritis and rheumatism.

[19]  M. Karsdal,et al.  Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen. , 2007, Osteoarthritis and cartilage.

[20]  F. Blanco,et al.  Lessons from the proteomic study of osteoarthritis , 2015, Expert review of proteomics.

[21]  Rajiv Gandhi,et al.  Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry , 2014, Clinical Proteomics.

[22]  Mary F. Lopez,et al.  Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis , 2014, Arthritis Research & Therapy.

[23]  E. Vignon,et al.  Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. , 2004, Osteoarthritis and cartilage.

[24]  A. Hofman,et al.  Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. , 2014, Osteoarthritis and cartilage.

[25]  L. Wehenkel,et al.  Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. , 2008, Clinical chemistry.

[26]  F. Blanco,et al.  Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. , 2010, Osteoarthritis and cartilage.

[27]  A. Uitterlinden,et al.  A new marker for osteoarthritis: cross-sectional and longitudinal approach. , 2004, Arthritis and rheumatism.

[28]  Gary D Bader,et al.  The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. , 2013, Journal of proteome research.

[29]  Johanne Martel-Pelletier,et al.  Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation , 2011, Annals of the rheumatic diseases.

[30]  E. Roos,et al.  Joint injury causes knee osteoarthritis in young adults , 2005, Current opinion in rheumatology.

[31]  M. Karsdal,et al.  Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. , 2015, Osteoarthritis and cartilage.

[32]  J. McKeon,et al.  Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. , 2011, Osteoarthritis and cartilage.

[33]  Mary F. Lopez,et al.  Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. , 2013, Arthritis and rheumatism.

[34]  N. Fukui,et al.  Identification of Potential Prognostic Markers for Knee Osteoarthritis by Serum Proteomic Analysis , 2013, Biomarker insights.

[35]  M. Glocker,et al.  Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. , 2004, Pathology, research and practice.

[36]  M. Englund,et al.  High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury. , 2004, Arthritis and rheumatism.

[37]  Manuel Fuentes,et al.  Analysis of autoantibody profiles in osteoarthritis using comprehensive protein array concepts. , 2014, Journal of proteome research.

[38]  F. Blanco,et al.  The role of proteomics in osteoarthritis pathogenesis research. , 2009, Current drug targets.

[39]  Liling Huang,et al.  Analysis of synovial fluid in knee joint of osteoarthritis:5 proteome patterns of joint inflammation based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry , 2011, International Orthopaedics.

[40]  J. Capelo-Martínez,et al.  Sequential depletion of human serum for the search of osteoarthritis biomarkers , 2012, Proteome Science.

[41]  T. Hankemeier,et al.  Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: method validation and peptide identification. , 2007, Journal of proteome research.

[42]  S Lohmander,et al.  OARSI guidelines for the non-surgical management of knee osteoarthritis. , 2014, Osteoarthritis and cartilage.

[43]  J. Dai,et al.  Identification of Osteoarthritis Biomarkers by Proteomic Analysis of Synovial Fluid , 2012, The Journal of international medical research.

[44]  T. Spector,et al.  Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. , 2006, Arthritis and rheumatism.

[45]  Y. Henrotin,et al.  Type II collagen markers in osteoarthritis: what do they indicate? , 2007, Current opinion in rheumatology.

[46]  O. Nemirovskiy,et al.  An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: Use as a biomarker for aggrecanase activity and cartilage degradation. , 2010, Analytical biochemistry.

[47]  J. Jordan,et al.  Associations Between Biomarkers of Joint Metabolism, Hand Osteoarthritis, and Hand Pain and Function: The Johnston County Osteoarthritis Project , 2014, The Journal of Rheumatology.

[48]  N. Oreiro,et al.  Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. , 2012, Journal of proteomics.

[49]  F. Blanco.  Osteoarthritis year in review 2014: we need more biochemical biomarkers in qualification phase. , 2014, Osteoarthritis and cartilage.

[50]  Peter J Millett,et al.  High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis , 2007, Arthritis research & therapy.

[51]  F. Lafeber,et al.  Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis , 2012, Annals of the rheumatic diseases.